Gross Profit: Revenues from operations less the associated costs.
Minerva Neurosciences, Inc (NERV) Gross Profit data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$16.65M |
|
-- |
|
|
Gross Profit |
-- |
$10.64M |
|
$-10.64M |
|
$28.11M |
|
$17.47M |
|
$17.47M |
|
$17.47M |
|
$17.47M |
|
$17.47M |
|
$17.47M |
|
$-10.64M |
|
$-11.04M |
|
46.60M |
|
79.10M |
|
$0.36 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$79.73M |
|
-- |
|
$15.36M |
|
$95.09M |
|
$3.96M |
|
-- |
|
$304.43M |
|
$308.39M |
|
$-213.30M |
|
$-228.17M |
|
$-213.30M |
|
47.23M |
|
| Cash Flow Statement Financials | |
$-18.77M |
|
$-50.13M |
|
$11.25M |
|
$82.40M |
|
$24.75M |
|
$-57.65M |
|
$10.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.19% |
|
-7.65% |
|
18.37% |
|
-8.19% |
|
$-4.52 |
|
$-0.24 |
|
$-0.24 |
|